OUTCOMES OF PATIENTS ≥ 65 YEARS OF AGE IN ZUMA‐1, A PIVOTAL PHASE 1/2 STUDY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) IN REFRACTORY LARGE B CELL LYMPHOMA. (12th June 2019) - Neelapu, S.S.